DevicePharm, along with six other Orange County professional services firms, co-sponsored the 2016 OCTANe LaunchPad ‘Company Of The Year’ award. The LaunchPad Program gave nine early-stage companies the opportunity to present to a panel of investors with the chance to receive a bundle of professional services ranging from brand development to intellectual property, reimbursement, and financial services.
Big Data. The term is ubiquitous in our culture and its importance was validated by the attendance of over 500 people at the leadoff panel during the OCTANe 2016 Medical Device and Investor Forum. The panel, titled “Using Big Data To Improve Patient Outcomes and Reimbursement” was hosted by DevicePharm CEO, Clay Wilemon.
Every medical marketer wants to know one thing, “What are my customers thinking?”. On November 10, 2016, DevicePharm and Medical Alley will co-host an event designed to answer that very question. Titled ‘Medical Device Marketing Through the Eyes of Your Customers’, this event will feature a panel that includes surgeons, interventionalists, and hospital and practice executives from the Twin Cities area.
Much-anticipated breast cancer results from the prospective, randomized clinical study known as MINDACT were published in the August 24, 2016 edition of the New England Journal of Medicine. The MINDACT study evaluated the MammaPrint® 70-Gene Breast Cancer Recurrence Assay in 6,693 patients to determine its ability to help physicians identify which early-stage breast cancer patients would, and would not, likely benefit from chemotherapy.
SkylineDx debuted its new MMprofiler™ with SKY92 campaign this year during the European Hematology Association conference in Denmark. MMprofiler with SKY92 enables physicians to quickly and confidently identify high-risk multiple myeloma patients.
DevicePharm, a marketing strategy and integrated marketing solutions firm, is pleased to announce the promotion of Joseph Bañuelos to Vice President, Creative Director. Joseph is a proven leader in brand development and campaign creation for healthcare marketing.
Irvine, CA and Minneapolis, MN (August 10, 2016) – DevicePharm, a marketing strategy and integrated marketing communications firm serving medical device, biotech, diagnostics, and pharmaceutical companies, announced today that Christine Horton has joined the firm as Vice President. She will be based in the firm’s rapidly growing Minneapolis office and will serve as a member of the leadership team.
The ReShape Medical website, ReShapeReady.com, has received widespread recognition from industry groups and physicians. Summit International Media recently added to the notoriety by recognizing the ReShape Medical website with its Leadership Award in the category of Health and Wellness Websites.
DevicePharm has been recognized as a Foundational Member of Medical Alley, the Minnesota-based organization focused on growing one of the world’s most prolific centers of healthcare technology and delivery innovation.
UK Trade & Investment — the business development arm of the British Consulate — invited DevicePharm CEO & Chief Strategy Officer, Clay Wilemon, to present to UK medical firms during a February conference.